In a newly announced partnership with Texas biotech company Colossal Biosciences, Australian researchers are hoping their dream to bring back the extinct thylacine is a “giant leap” closer to fruition.
Scientists at University of Melbourne’s TIGRR Lab (Thylacine Integrated Genetic Restoration Research) believe the new partnership, which brings Colossal’s expertise in CRISPR gene editing on board, could result in the first baby thylacine within a decade.
